Works matching AU Pinto, Antonello

Results: 19

Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7441, doi. 10.3390/jcm13237441

By:

Fedele, Palma;
Landriscina, Matteo;
Moraca, Lucia;
Gadaleta-Caldarola, Arianna;
Cusmai, Antonio;
Giuliani, Francesco;
Chiuri, Vincenzo;
Giotta, Francesco;
Pinto, Antonello;
Mirisola, Valentina;
Gadaleta-Caldarola, Gennaro

Publication type:

Article

Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients.

Published in:

Oncologist, 2015, v. 20, n. 12, p. 1413, doi. 10.1634/theoncologist.2015-0227

By:

Zinzani, Pier Luigi;
Pellegrini, Cinzia;
Cantonetti, Maria;
Re, Alessandro;
Pinto, Antonello;
Pavone, Vincenzo;
Rigacci, Luigi;
Celli, Melania;
Broccoli, Alessandro;
Argnani, Lisa;
Pulsoni, Alessandro

Publication type:

Article

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub‐Study of the FOLL12 Trial.

Published in:

American Journal of Hematology, 2025, v. 100, n. 7, p. 1196, doi. 10.1002/ajh.27711

By:

Durmo, Rexhep;
Chauvie, Stephane;
Minoia, Carla;
Bergesio, Fabrizio;
Fallanca, Federico;
Peano, Simona;
Marcheselli, Luigi;
Anastasia, Antonella;
Boccomini, Carola;
Corradini, Paolo;
Olivieri, Jacopo;
Arcaini, Luca;
Cavallo, Federica;
Ibatici, Adalberto;
Nassi, Luca;
Tarantino, Vittoria;
Pinto, Antonello;
Stelitano, Caterina;
Pulsoni, Alessandro;
Ricci, Francesca

Publication type:

Article

Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.

Published in:

Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146

By:

Pinto, Antonello;
Guarini, Chiara;
Giampaglia, Marianna;
Sanna, Valeria;
Melaccio, Assunta;
Lanotte, Laura;
Santoro, Anna Natalizia;
Pini, Francesca;
Cusmai, Antonio;
Giuliani, Francesco;
Gadaleta-Caldarola, Gennaro;
Fedele, Palma

Publication type:

Article

Role of Rituximab Addition to First‐line Chemotherapy Regimens in Nodular Lymphocyte‐predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.

Published in:

HemaSphere, 2023, v. 7, n. 4, p. e837, doi. 10.1097/HS9.0000000000000837

By:

Gotti, Manuel;
Sciarra, Roberta;
Pulsoni, Alessandro;
Merli, Francesco;
Luminari, Stefano;
Zerbi, Caterina;
Trentin, Livio;
Re, Alessandro;
Rusconi, Chiara;
Viviani, Simonetta;
Rossi, Andrea;
Cocito, Federica;
Botto, Barbara;
Meli, Erika;
Pinto, Antonello;
Dogliotti, Irene;
Gini, Guido;
Puccini, Benedetta;
Ricci, Francesca;
Nassi, Luca

Publication type:

Article

A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 4, p. 880, doi. 10.3109/10428194.2015.1091934

By:

Luminari, Stefano;
Goldaniga, Maria;
Cesaretti, Marina;
Orsucci, Lorella;
Tucci, Alessandra;
Pulsoni, Alessandro;
Salvi, Flavia;
Arcaini, Luca;
Carella, Angelo Michele;
Tedeschi, Alessandra;
Pinto, Antonello;
Stelitano, Caterina;
Baldini, Luca

Publication type:

Article

Recurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 1969, doi. 10.3109/10428194.2014.981174

By:

Pinto, Antonello;
Corradini, Paolo;
Mussetti, Alberto;
Zinzani, Pier Luigi

Publication type:

Article

The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 1, p. 12, doi. 10.3109/10428194.2014.894187

By:

Zinzani, Pier Luigi;
Federico, Massimo;
Oliva, Stefano;
Pinto, Antonello;
Rigacci, Luigi;
Specchia, Giorgina;
Tucci, Alessandra;
Vitolo, Umberto

Publication type:

Article

Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics.

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 1, p. 9, doi. 10.1080/14740338.2024.2419547

By:

Guarini, Chiara;
Santoro, Anna Natalizia;
Melaccio, Assunta;
Lanotte, Laura;
Gadaleta-Caldarola, Gennaro;
Giuliani, Francesco;
Pinto, Antonello;
Fedele, Palma

Publication type:

Article

A phase II study of dose-dense and dose-intense ABVD ( ABVD<sub>DD-DI</sub>) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.

Published in:

British Journal of Haematology, 2014, v. 166, n. 1, p. 118, doi. 10.1111/bjh.12862

By:

Russo, Filippo;
Corazzelli, Gaetano;
Frigeri, Ferdinando;
Capobianco, Gaetana;
Aloj, Luigi;
Volzone, Francesco;
De Chiara, Annarosaria;
Bonelli, Annamaria;
Gatani, Tindaro;
Marcacci, Gianpaolo;
Donnarumma, Daniela;
Becchimanzi, Cristina;
Lutio, Elisabetta;
Ionna, Franco;
De Filippi, Rosaria;
Lastoria, Secondo;
Pinto, Antonello

Publication type:

Article

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.

Published in:

2022

By:

Rieger, Kathrin;
De Filippi, Rosaria;
Lindén, Ola;
Viardot, Andreas;
Hess, Georg;
Lerch, Kristina;
Neumeister, Peter;
Stroux, Andrea;
Peuker, Caroline A.;
Pezzutto, Antonio;
Pinto, Antonello;
Keller, Ulrich;
Scholz, Christian W.

Publication type:

journal article

Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside.

Published in:

Biology (2079-7737), 2024, v. 13, n. 6, p. 409, doi. 10.3390/biology13060409

By:

Fedele, Palma;
Santoro, Anna Natalizia;
Pini, Francesca;
Pellegrino, Marcello;
Polito, Giuseppe;
De Luca, Maria Chiara;
Pignatelli, Antonietta;
Tancredi, Michele;
Lagattolla, Valeria;
Anglani, Alessandro;
Guarini, Chiara;
Pinto, Antonello;
Bracciale, Pietro

Publication type:

Article

Efficacy of <sup>90</sup>Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.

Published in:

Hematological Oncology, 2014, v. 32, n. 1, p. 10, doi. 10.1002/hon.2078

By:

Vanazzi, Anna;
Grana, Chiara;
Crosta, Cristiano;
Pruneri, Giancarlo;
Rizzo, Stefania;
Radice, Davide;
Pinto, Antonello;
Calabrese, Liliana;
Paganelli, Giovanni;
Martinelli, Giovanni

Publication type:

Article

Efficacy of ⁹⁰Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.

Published in:

2014

By:

Vanazzi, Anna;
Grana, Chiara;
Crosta, Cristiano;
Pruneri, Giancarlo;
Rizzo, Stefania;
Radice, Davide;
Pinto, Antonello;
Calabrese, Liliana;
Paganelli, Giovanni;
Martinelli, Giovanni

Publication type:

journal article

Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review.

Published in:

Cancers, 2024, v. 16, n. 23, p. 4082, doi. 10.3390/cancers16234082

By:

Gadaleta-Caldarola, Gennaro;
Lanotte, Laura;
Santoro, Anna Natalizia;
Pinto, Antonello;
Gadaleta-Caldarola, Arianna;
Giacomelli, Luca;
Fedele, Palma

Publication type:

Article

Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.

Published in:

Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442

By:

Fedele, Palma;
Landriscina, Matteo;
Moraca, Lucia;
Cusmai, Antonio;
Gnoni, Antonio;
Licchetta, Antonella;
Guarini, Chiara;
Lanotte, Laura;
Pappagallo, Maria Nicla;
Melaccio, Assunta;
Giordano, Guido;
Maselli, Felicia Maria;
Pinto, Antonello;
Giuliani, Francesco;
Chiuri, Vincenzo;
Giotta, Francesco;
Gadaleta-Caldarola, Gennaro

Publication type:

Article

Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry.

Published in:

Acta Haematologica, 2021, v. 144, n. 3, p. 259, doi. 10.1159/000509923

By:

Zinzani, Pier Luigi;
Bregni, Marco;
Spione, Mario;
Mitterer, Manfred;
Musuraca, Gerardo;
Bugli, Annamaria;
Piazza, Francesco;
Pinto, Antonello

Publication type:

Article

Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: reply to D'Arco et al.

Published in:

British Journal of Haematology, 2015, v. 171, n. 4, p. 665, doi. 10.1111/bjh.13430

By:

Pinto, Antonello;
Corazzelli, Gaetano

Publication type:

Article

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics.

Published in:

mAbs (1942-0862), 2013, v. 5, n. 6, p. 826, doi. 10.4161/mabs.26008

By:

Golay, Josée;
Semenzato, Gianpietro;
Rambaldi, Alessandro;
Foà, Robin;
Gaidano, Gianluca;
Gamba, Enrica;
Pane, Fabrizio;
Pinto, Antonello;
Specchia, Giorgina;
Zaja, Francesco;
Regazzi, Mario

Publication type:

Article